Self-Diagnosis of SARS-CoV-2 from Saliva Samples at Home: Isothermal Amplification Enabled by Do-It-Yourself Portable Incubators and Laminated Poly-ethyl Sulfonate Membranes
Bravo-González et al.
The finding, in our words
A do‑it‑yourself incubator enabling LAMP amplification of SARS‑CoV‑2 RNA from self‑collected saliva achieved 100 per cent sensitivity and 87 per cent selectivity in a proof‑of‑concept deployment to more than 15 homes, offering a simple, low cost route to decentralised molecular diagnostics.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.
Oral sponge saliva RT-PCR achieved 95% sensitivity and 95% specificity compared with nasopharyngeal swabs in 3,488 symptomatic and asymptomatic adults, while buccal swab performance varied with infection history and symptoms. The rapid antigen test showed 66.9% sensitivity overall, increasing to 97% in high viral load samples. Oral sponge collection permits self-sampling without laboratory pre-analytical steps, offering a robust method for decentralised SARS-CoV-2 screening.
Self-collected saliva specimens yielded high-quality results for SARS-CoV-2 PCR and whole-genome sequencing in an occupational screening programme, with variant determination achieved in 67–83 per cent of positive samples. The study shows that PCR cycle threshold cut-offs critically influence sequencing success, supporting decentralised genomic surveillance for respiratory pathogens.
Saliva-based RT-PCR for SARS-CoV-2 achieved 100 per cent sensitivity and 97 per cent specificity against nasopharyngeal swabs, while rapid antigen testing on saliva showed comparable performance and detected 97 per cent of infectious cases with cycle threshold values of 30 or below. This supports saliva self-collection as an accurate, practical option for decentralised COVID-19 screening.
A coffee-ring biosensor detected sepsis, COVID-19 and cancer proteins from self-collected saliva down to 3 pg/ml within 12 minutes, achieving sensitivity more than 100-fold higher than lateral flow assays. The system uses a smartphone camera and AI analysis, providing a rapid, affordable platform for decentralised protein diagnostics.
In confirmed COVID-19 patients, direct RT-PCR on self-collected raw saliva detected all cases (100% sensitivity) with 94.3% concordance to nasopharyngeal swabs. Guanidine-based and guanidine-free inactivators reduced sensitivity to 65.9% and 82.9% respectively. Raw saliva offers a reliable patient-centric alternative for decentralised SARS-CoV-2 testing without sample treatment.